INTRODUCTION: DISPATCHES FROM THE GUILD CONFERENCE 2018Dispatches from the GUILD Conference 2018
DISPATCHES FROM THE GUILD CONFERENCE, SERIES #10A New Model of Specialty Care -The Inflammatory Bowel Disease Medical Home
In this manuscript, we review the concept of patient-centered specialty medical homes, potential reimbursement methods, implementation requirements and potential challenges. We also present the process and considerations of developing a specialty medical home, and review our experience with an IBD specialty medical home. We further discuss other alternative value-based IBD models being studied across the country.
NUTRITION ISSUES IN GASTROENTEROLOGY, SERIES #173Food for Thought - Importance of Nutrition in Alcoholic Hepatitis
Acute alcoholic hepatitis (AAH) is the most severe form of alcoholic liver disease, yet many patients suffering from this syndrome are not diagnosed or are inadequately treated. Nutritional support is an essential component of treatment as malnutrition has been associated with poorer outcomes. The role of adjunctive nutritional support, including enteral feeding and specific supplemental micronutrients, needs to be better delineated as it relates to altering clinical outcomes. Here, we review the nutritional aspects of patients with AAH and the effect implementation of various dietary interventions have on clinical outcomes of this frequently deadly condition.
THE MICROBIOME AND DISEASE, SERIES #3The Microbiome and Obesity
There is a growing body of research suggesting that obesity, metabolic syndrome, and insulin resistance are associated with predictable phyla and gene level compositional changes in the intestinal microbiome of humans and mice. With a better understanding of these changes, we can develop new, robust therapeutic strategies. In this article, we will briefly discuss some of the definitive research related to the microbiome and its impact on obesity and other metabolic derangements.
A CASE REPORTLeiomyosarcoma of the Inferior Vena Cava
STERIS RECEIVES INNOVATIVE TECHNOLOGY DESIGNATION FROM VIZIENT FOR VERIFY® ALL-IN-ONE REUSABLE TEST PACK AND VERIFY® ASSERTTM SELF-CONTAINED BIOLOGICAL INDICATOR
Mentor, OH - STERIS announced its VERIFY AllIn-One Reusable Test Pack and VERIFY Assert Self Contained Biological Indicator have each received a 2017 Innovative Technology designation from Vizient, Inc., the nation's largest member-driven health care performance improvement company. The designations are based on direct feedback from hospital experts who interacted with the VERIFY All-In-One Reusable Test Pack and VERIFY Assert Self Contained Biological Indicator at the Vizient Innovative Technology Exchange held in Denver, on September 14, 2017.